Section: 
School of pharmacotherapy
School of pharmacotherapyImport-substituting pharmacological technologies in otorhinolaryngology
Yu. K. Yanov (1), S. V. Ryazantsev (1), M. A. Budkovaya (1)
(1) Federal State Budgetary Institution “Saint Petersburg Research Institute of Ear, Throat, Nose and Speech”, Ministry of Health of the Russian Federation, Saint Petersburg, Russia
UDK: 616.014:616.216.1-002(470.23-25):338.24
DOI: https://doi.org/10.18692/1810-4800-2017-2-170-176
ABSTRACT
The article presents pharmaceutical products of St. Petersburg company VERTEX in the field of otorhinolaryngology. The authors provide detailed description of the medical preparations, produced by VERTEX for treatment of patients with ENT diseases; special attention is paid to the preparation NOZEFRIN® – the first Russian spray – analogue of Mometasone furoate. The analysis of this pharmaceutical company operation discloses its participation in the development and implementation of import-substituting technologies in the Russian Federation in the field of pharmacology.
Publication date:
06.05.2017
Keywords:
mometasone furoate, rhinosinusitis, preparations, corticosteroids, nozefrin. For citation:
Yanov Yu. K., Ryazantsev S. V., Budkovaya M. A. Import-substituting pharmacological technologies in otorhinolaryngology. Rossiiskaya otorinolaringologiya. 2017;2:170–176. https://doi.org/10.18692/1810-4800-2017-2-170-176